Accession Number: | 0001447362-21-000148 |
Date: | 2021-06-15 |
Issuer: | CASTLE BIOSCIENCES INC (CSTL) |
Original Submission Date: |
STOKES FRANK
C/O CASTLE BIOSCIENCES, INC.
505 S. FRIENDSWOOD DRIVE, SUITE 401
FRIENDSWOOD, TX 77546
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-15 | M | 11,600 | a | $2.39 | 17,520 | direct | ||
COMMON STOCK | 2021-06-15 | S | 11,600 | d | $73.02 | 5,920 | direct | ||
COMMON STOCK | 2021-06-16 | M | 2,127 | a | $2.39 | 8,047 | direct | ||
COMMON STOCK | 2021-06-16 | S | 2,127 | d | $73.07 | 5,920 | direct | ||
COMMON STOCK | 2021-06-17 | M | 1,273 | a | $2.39 | 7,193 | direct | ||
COMMON STOCK | 2021-06-17 | S | 1,273 | d | $73.00 | 5,920 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.39 | 2021-06-15 | deemed execution date | M | 11,600 (d) | 2028-05-09 | common stock 11,600 | $2.39 | 28,537 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.39 | 2021-06-16 | deemed execution date | M | 2,127 (d) | 2028-05-09 | common stock 2,127 | $2.39 | 26,410 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.39 | 2021-06-17 | deemed execution date | M | 1,273 (d) | 2028-05-09 | common stock 1,273 | $2.39 | 25,137 | direct |
ID | footnote |
---|---|
f1 | these transactions were made pursuant to a rule 10b5-1 plan adopted by the reporting person on may 14, 2021. |
f2 | includes 2,034 shares acquired on february 26, 2021 under the issuer's employee stock purchase plan. |
f3 | this transaction was executed in multiple trades at prices ranging from $73.00 to $73.13, inclusive. the price reported above reflects the weighted-average sale price. the reporting person hereby undertakes to provide upon request to the securities and exchange commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f4 | this transaction was executed in multiple trades at prices ranging from $73.00 to $73.33, inclusive. the price reported above reflects the weighted-average sale price. the reporting person hereby undertakes to provide upon request to the securities and exchange commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f5 | the option is exercisable immediately, in whole or in part, conditioned upon the reporting person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on december 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. |